Of relevance, due to a higher number of cases analyzed, our study confirmed that PTEN loss is an event predominantly occurring in metastases instead of in primary tumors [19], thus suggesting that PTEN mutations are supposedly acquired later during tumor progression. The gene discussed is PTEN; the disease is neoplasm.